Trade Shows

Trade Resources Search Results

Type

Location

Industry

View More

2 results for "

alendronate sodium

"

Romosozumab Is an Investigational Medicine in Phase 3 Clinical Development
Jan 3, 2014
Amgen (NASDAQ: AMGN) and UCB (Euronext Brussels:UCB) today announced results from a Phase 2 trial evaluating romosozumab (AMG 785/CDP7851) in postmenopausal women with low bone mineral density (BMD). Published in the New England Journal of ...

Tags: Amgen, UCB, Phase 2 trial evaluating romosozumab, postmenopausal women
EffRx Has Launched a New Effervescent Buffered Oral Solution for Osteoporosis Treatment
Nov 28, 2012
EffRx Pharmaceuticals has launched a new effervescent buffered oral solution (70mg), designed for the treatment of osteoporosis, in the US. The new solution, BINOSTO (alendronate sodium), is intended for the treatment of osteoporosis in ...

Tags: oral solution, osteoporosis, alendronate sodium

Related Products